Please login to the form below
Mission
This page shows the latest Mission news and features for those working in and with pharma, biotech and healthcare.
Ovid wins Communiqué Small Consultancy of the Year award at Communiqué 2021
Our mission is patient-centred and we did not shy away from this in 2020-21, which makes this achievement even sweeter.
Latest news
-
Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
Little is known about Kumquat’s platform, although the company says its mission is ‘to develop innovative therapies to bring about sustainable and life-changing benefits to cancer patients’.
-
Resilience acquires bluebird bio’s manufacturing facility as part of cell therapy alliance
Our mission of developing the next generation of cell therapies requires a thoughtful balance of innovation from both a scientific, medical and regulatory perspective, as well as a manufacturing perspective. ... We believe Resilience is an optimal
-
EU approves bluebird bio’s CALD gene therapy Skysona
bluebird bio was founded with the mission of developing a therapy to recode CALD on the genetic level, and today’s announcement represents over twenty years of research and development that
-
Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
This is another critical step in the BlueRock mission to create authentic cellular medicines to reverse devastating diseases, with the vision of improving the human condition,” he added.
-
Kriya Therapeutics raises $100m to further develop gene therapies with ‘broader applications’
Kriya was formed with the mission of revolutionising how gene therapies are designed, developed and produced by fully integrating advanced manufacturing technologies, computational tools and development capabilities within a single company.
Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
Resilience acquires bluebird bio’s manufacturing facility as part of cell therapy alliance
EU approves bluebird bio’s CALD gene therapy Skysona
Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
More from news
Approximately 0 fully matching, plus 249 partially matching documents found.
Latest Intelligence
-
Product launches: making the most of your one shot
Linking to mission control: digital launch execution platforms. This is where modern launch readiness software comes in.
-
Launch engagement
were a space shuttle or satellite, mission control would have aborted for more favourable conditions.
-
New thinking, bold action: building a better future for people living with severe diseases
Our investments in digital tools helped us not only get through 2020 but allowed us to seamlessly continue our mission to bring new value to the patient experience. ... In our mission to better serve all who live with severe diseases, we announced new
-
Why digital is the solution to the healthcare crisis
Its global mission is to contain the pandemic by building a foundational public health technology platform and mobile apps that make digital contact tracing, case management, epidemiological information collection and citizen
-
How can virtual pharma companies de-risk new product launches?
If this isn’t in place, pharma companies may underestimate the costs involved in bringing in mission-critical partners or meeting key requirements, without which they can’t launch.
Product launches: making the most of your one shot
Launch engagement
New thinking, bold action: building a better future for people living with severe diseases
Why digital is the solution to the healthcare crisis
How can virtual pharma companies de-risk new product launches?
More from intelligence
Approximately 0 fully matching, plus 60 partially matching documents found.
Latest appointments
-
Hanover Health appoints Aleksandra Lugović as an associate director
My mission will be to foster an environment where we look beyond the current, already familiar challenges, and focus on what is most certainly coming,”commented Lugović.
-
Merck & Co appoints Frank Clyburn as president, human health
I look forward to continuing to work with him as we advance Merck’s mission to save and improve lives,” he added.
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
I am honoured to join the AMR Action Fund and its incredibly important mission.
-
Syneos Health appoints Tim Pantello as president of communications
proving mission critical to our customers during this transformative time,” said Keefe.
-
Streaming Well to “raise the bar in pharma film making”
Together, our mission is to raise the bar on what HCP and patient engagement looks like for the healthcare industry through powerful storytelling and interactive experiences.
Hanover Health appoints Aleksandra Lugović as an associate director
Merck & Co appoints Frank Clyburn as president, human health
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
Syneos Health appoints Tim Pantello as president of communications
Streaming Well to “raise the bar in pharma film making”
More from appointments
Approximately 2 fully matching, plus 62 partially matching documents found.
Latest from PMHub
-
Clark Health Communications and Egg digital announce new collaboration
Our mission is to provide communications that Deliver Change for patients and healthcare professionals around the world. In 2018 it’s no longer enough that we know how to use digital
-
RESONANT GROUP ACQUIRES PR BUSINESS
Affirms Resonant’s mission to enable effective engagement in health. 13 September 2021 - In line with Resonant’s mission to enable effective engagement in health, the Group today announced the strategic ... With this front of mind, its mission is to
-
DOVETAIL & IBD REGISTRY WIN AGILITY AND FLEXIBILITY AWARD AT COMMUNIQUÉ 2021
Find out more about Dovetail and our mission to transform healthcare hand in hand here.
-
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
If you’re interested in getting involved in our mission to Demand Diversity, get in touch at ash@demanddiversity.co.
-
COUCH Health Engages Mark Duman as Chief Strategy Officer
Taking charge of strategy development and execution for COUCH Health, Mark will oversee the expansion of COUCH Health’s mission to contribute to inclusive clinical trials that prioritise the patient experience.
DOVETAIL & IBD REGISTRY WIN AGILITY AND FLEXIBILITY AWARD AT COMMUNIQUÉ 2021
#DemandDiversity: Why cultural safety is an important step towards achieving diversity in clinical trials
COUCH Health Engages Mark Duman as Chief Strategy Officer
More from PMHub
Approximately 1 fully matching, plus 168 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- US demand for COVID-19 antibody treatments rising fast
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- New data from Moderna supports COVID boosters
- $47.5m research centre to seek genetic insights into disease
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Nicky Hutchens appointed as deputy managing director at Four Health
- Health For All
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- David Hunt launches independent agency The Considered
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- Live Webinar: Making Actionable Health Information More Accessible Through Point-of-Care Testing
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Patient diversity in clinical trials needs to be centre stage
PMHub
Madmicrobe Studios - Medical Animation
MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
